Ligand · A9F
A9F · N-{[3-({[(1R,2S)-2-{[(2E)-2-cyano-4,4-dimethylpent-2-enoyl]amino}cyclopentyl]oxy}methyl)phenyl]methyl}-4-[(4-methylpiperazin-1-yl)methyl]benzamide
A9F, N-{[3-({[(1R,2S)-2-{[(2E)-2-cyano-4,4-dimethylpent-2-enoyl]amino}cyclopentyl]oxy}methyl)phenyl]methyl}-4-[(4-methylpiperazin-1-yl)methyl]benzamide (C34 H45 N5 O3, 571.8 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record…
- Component
- A9F
- Formula
- C34 H45 N5 O3
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A9F in 1 structure; the first of them:
- 6IJS · Human ppargamma ligand binding domain complexed with SB1494 · A9F A501 · binds PHE226, ALA278, ILE281, PHE282, CYS285, GLN286, ARG288, SER289 and 15 more
Residues it binds most
LEU 1, PHE 1, ILE 1, MET 1, ALA 1, TYR 1, ARG 1, CYS 1, GLN 1, HIS 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.